VEL-101

· Veloxis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VEL-101, covering 2024-06-27 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: VEL-101 to Prevent Rejection After Kidney Transplantation [Phase 2]